JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 8 June 2009

Journal of Endocrinology 2009;202:407.

Journal of Endocrinology (2009) In press
DOI: 10.1677/JOE-09-0109
© 2009 Society for Endocrinology
This Article
Right arrow Accepted manuscript (PDF)
Right arrow All Versions of this Article:
JOE-09-0109v1
JOE-09-0109v2
202/3/407    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Chen, Y.
Right arrow Articles by Pepling, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y.
Right arrow Articles by Pepling, M.

RESEARCH

Estrogen Can Signal through Multiple Pathways to Regulate Oocyte Cyst Breakdown and Primordial Follicle Assembly in the Neonatal Mouse Ovary

Ying Chen, Kelsey Breen and Melissa Pepling

Y Chen, Biology, Syracuse University, Syracuse, United States
K Breen, Biology, Syracuse University, Syracuse, United States
M Pepling, Biology, Syracuse University, Syracuse, United States

Correspondence: Melissa Pepling, Email: mepeplin{at}syr.edu

During mouse embryonic development, oocytes develop in germline cysts, formed by several rounds of cell division followed by incomplete cytokinesis. Shortly after birth, cysts break down and individual oocytes are enclosed by granulosa cells to form primordial follicles. At the same time, two thirds of the oocytes die by apoptosis with only one third surviving. We have previously shown that the steroid hormones, estradiol (E2) and progesterone, as well as the phytoestrogen genistein can inhibit cyst breakdown and primordial follicle assembly. However, the mechanisms by which steroid hormones regulate oocyte cyst breakdown and selective oocyte survival are unknown. Here, we confirmed expression of estrogen receptor (ER) mRNA and protein in neonatal mouse ovaries using RT-PCR, Western blotting and immunocytochemistry. We then used estrogen receptor specific agonists and antagonists to understand the mechanism of estrogen signaling. PPT, an ER{alpha} selective agonist and DPN, an ERβ selective agonist both inhibited cyst breakdown in organ culture, suggesting that E2 can signal through both receptors to regulate cyst breakdown. ICI 182,780, an estrogen receptor antagonist completely blocked E2’s action. MPP, an ER{alpha} specific antagonist fully blocked E2’s effect on oocyte cyst breakdown and primordial follicle assembly and (R,R)-THC, an ERβ specific antagonist, partially blocked E2, further supporting the idea that both receptors are involved in estrogen signaling in neonatal oocyte development. E2 conjugated to BSA which can only exert effects at the membrane, was able to inhibit cyst breakdown, implying that E2 could also function through a membrane bound estrogen receptor to regulate cyst breakdown.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the Society for Endocrinology.